Innovations in Chemotherapy Personalization, Cell Transplants, Multi-drug Resistance Studies, and Adult Stem Cell Regeneration

  • ID: 4580201
  • Report
  • Region: Global
  • 15 Pages
  • Frost & Sullivan
1 of 3

The Genetic Technology TechVision Opportunity Engine (TOE) presents trends across chemotherapy personalization, cell transplantation, multi-drug resistance studies, and adult stem cell regeneration. The corresponding clinical trials scenario related to monoclonal antibody drugs for autoimmune diseases is also depicted.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Note: Product cover images may vary from those shown
2 of 3

1. Recent Advances in Chemotherapy Personalization, Cell Transplants, Multi-drug Resistance Studies and Adult Stem Cell Regeneration
Chemotherapy Genetic Interaction Map for Personalized Treatment
Pancreatic Cell Transplant Capable of Vascularization
Decoding Acinetobacter Baumannii’s Multi-drug Resistance
Adult Stem Cell Regeneration by Fasting

2. Clinical Trial Analysis and Key Contacts
Clinical Trial Analysis of Monoclonal Antibody Drugs for Autoimmune Diseases
Key Contacts

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll